University of Toronto

  1. Metcalfe, K., Langstaff, J., Evans, S., Paterson, H., & Reid, J.  (1998).  Meeting the needs of women living with HIVPublic Health Nursing,15 (1), pp 30-34.
  2. Liede, A., Metcalfe, K., Offit, K., Brown, K., Miller, S., Narod, S., & Moslehi.  (1998).  A family with three germline mutations in BRCA1 and BRCA2. Clinical Genetics, (63), pp 128-130.
  3. Metcalfe, K., Liede, A., Hoodfar, E., Foulkes, W., & Narod, S. (2000).  An evaluation of needs among female BRCA1 and BRCA2 carriers undergoing genetic counselingJournal of Medical Genetics, 37 (11), pp 866-874.
  4. Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., Durham, C., Lynch, H., & Narod, S.  (2000).    Evaluation of the Needs of Male Carriers of Mutations in BRCA1 or BRCA2 Who Have Undergone Genetic CounsellingAmerican Journal of Human Genetics, 67 (6), pp 1494-1504.
  5. Elit, L., Metcalfe, K., Goel, V., & Narod, S.  (2001).  Patterns of hospital administrative and ethical review processes.  Annals of the Royal College of Physicians and Surgeons of Canada , 34:(4),  pp. 206-209.
  6. Metcalfe, K., Goel, V., Lickley, L., Semple, J., & Narod, S.  (2002). Prophylactic bilateral mastectomy: Patterns of practiceCancer, 95(2), pp. 236-242.
  7. Metcalfe, K. & Narod, S.  (2002).  Breast cancer risk in women with prophylactic mastectomy: A comparison of patients’ subjective and model-generated risk estimatesJournal of the National Cancer Institute, 94 (20), pp. 1564-1569.
  8. Metcalfe, K.., Liede, A., Trinkaus, M., Hanna, D., & Narod, S.  (2002).  Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2.  Clinical Genetics, 62, pp. 464-469.
  9. Foulkes, WD, Metcalfe, K, Hanna, W, Lynch HT, Ghadirian, P, Tung, N, Olopade, O, Weber, B, McLennan, J, Olivotto, O, Sun, P, Chappuis, PO, Begin, LR, Brunet, JS,  Narod, SA.  (2003). Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer, 98(8), pp. 1569-1577. 
  10. Metcalfe, K., Esplen, M.J., Goel, V., & Narod, S.  (2004).  Psychosocial functioning in women who have undergone bilateral prophylactic mastectomyPsycho-Oncology, 13, pp. 14-25.
  11. Menkiszak, J., Rzepka-Gorska, I., Gorski, B., Gronwald, J., Huzarski, T., Byrski. T., Jakubowska, A., Metcalfe, K., Narod, S., & Lubinski, J.  (2004).  Attitudes toward preventive oophorectomy among BRCA1 carriers in PolandEuropean Journal of Gynecological Oncology, 25(1), pp. 93-95.
  12. Foulkes, WD, Metcalfe, K, Sun, P., Hanna, W, Lynch HT, Ghadirian, P, Tung, N, Olopade, O, Weber, B, McLennan, J, Olivotto, O, Begin, LR, & Narod, SA.  (2004).  Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological typeClinical Cancer Research,10(6), pp. 2029-2034. 
  13. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2004).  The risk of contralateral breast cancer in BRCA1 and BRCA2 Carriers. Journal of Clinical Oncology, 22(12), pp.2328-35. 
  14. Metcalfe, K., Semple, J., & Narod, S.  (2004).  Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: A descriptive study. Plastic and Reconstructive Surgery, 114(2), pp. 360-366.
  15. Metcalfe, K. (2004).  Prophylactic bilateral mastectomy for breast cancer preventionJournal of Women’s Health,13(7), pp. 822-829. 
  16. Esplen, M.J.,  Hunter, J.,  Leszcz, M., Warner, E., Narod, S., Metcalfe, K., Butler, K.,  Liede, A., Young, M.A., Kieffer, S., DiProspero, L. & Irwin, E. (2004).  A multi-centre phase II study of supportive-expressive group therapy for women with BRCA1/2.  Cancer, 101(10), pp. 2327-2340.
  17. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2005).  The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 Carriers. Gynecologic Oncology, 96(2005), pp.222-226.
  18. Metcalfe, K., Esplen, M.J., Goel, V., & Narod, S.  (2005).  Predictors of quality of life in women with bilateral prophylactic mastectomyThe Breast Journal,11(1), pp.65-69. 
  19. Metcalfe, K, Seidel, J, Hanna, D, Snyder, C, Lynch, H, & Narod, S. (2005).  The use of preventive measures among health women who carry a BRCA1 or BRCA2 mutationFamilial Cancer, 4(2), pp.97-103.
  20. Metcalfe, K, Semple, J. & Narod, S.  (2005).  Time to reconsider subcutaneous mastectomy for breast cancer prevention?   The Lancet Oncology, 696), pp.431-434. 
  21. Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, Moller P, Neuhausen SL, Metcalfe K, Sun P, Narod SA. (2005).  A comparison of bilateral breast cancers in BRCA carriers. Cancer Epidemiology, Biomarkers and Prevention . 14(6):pp.1534-8.
  22. Metcalfe, K, Foulkes, W, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2005). The Effect of Prior Bilateral Salpingo-Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers . Hereditary Factors in Clinical Cancer, 3(2), pp. 53-57. 
  23. Lynch, HT, Snyder, C, Lynch, JF, Karatoprakli, P, Coronel, S, Trowonou, A, Metcalfe, K, Narod, SA ,Gong, G. (2006).  Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer familiesCancer Genetics and Cytogenetics, 165, pp.91-97. 
  24. Gronwald,J, B Górski,B, Huzarski, T, Byrski, T, Metcalfe,K, Narod, S, Lubiński, J.  Direct-to-Patient BRCA1 Testing: the Twoj Styl Experience . (2006) Breast Cancer Research and Treatment, 100(3):239-45. 
  25. Metcalfe, K, Ghadirian, P., Rosen, B., Foulkes, W., Kim-Sing, C., Eisen, A., Ainsworth, P., Horsman, D., Maugard, C., Provencher, D., Robidoux, A., Gilchrist, D., Chudley, A., Lemire, E., Sun, P., & Narod, S. (2007). Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers Across Canada, Open Medicine, 1(2): E92-98. 
  26. Metcalfe, K, Poll, A., O’Connor, A., Gershman, S., Armel, S., Finch, A., Demsky, R., Rosen, B., & Narod, S. (2007).  Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutationClinical Genetics, 72: 208-217. 
  27. Metcalfe, K. & Narod, S. (2007). The Prevention of Hereditary Breast Cancer, Open Medicine, 1(3): 184-190. 
  28. Metcalfe, K., Birenbaum-Carmeli. D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., Ghadirian, P., Foulkes, W., Friedman, E., Kim-Sing, C., Ainsworth, P., Rosen, B., Domchek, S., Wagner, T., Tung, N., Manoukian, S., Couch, F., Sun, P., & Narod, S. (2008). International Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers. International Journal of Cancer, 122(9): 2017-2022. 
  29. Metcalfe, K., Lubinski, J., Ghadirian, P., Lynch, H., Kim-Sing, C., Friedman, E., Foulkes, Domchek, S., Ainsworth, P., Isaacs, C., Tung, N., Gronwald, J., Cummings, S., Wagner, T., Manoukian, S., Moller, P., Sun, P., & Narod, S. (2008).  Predictors of Contralateral Prophylactic Mastectomy in Women with a BRCA1 or BRCA2 MutationJournal of Clinical Oncology, 26(7): 1093-1097. 
  30. Metcalfe, K., Ghadirian, P., Foulkes, W., Kim-Sing, C., Ainsworth, P., Rosen, B., Armel, S., Poll, A., Eisen, A., Gilchrist, D., Chudley, A., Maugard, C., Lemire, E., Sun, P., & Narod, S. (2008) Family History as a Predictor of Uptake of Cancer Preventive Procedures by Women with a BRCA1 or BRCA2 Mutation. Clinical Genetics, 73(5). 474-479.
  31. Finch, A., Metcalfe, K. Lui, J., Springate, C., Demsky, R., Rosen, B., Murphy, J., Sun, P., & Narod, S.  (2009).  Breast and Ovarian Cancer Risk Perception Among Women That Have Undergone Prophylactic Salpingo-Oophorectomy Due to Inherited Mutations in the BRCA1 and BRCA2 Genes. Clinical Genetics 75(3):220-4..
  32. Metcalfe, K. Fan, I., McLaughlin, J., Risch, H., Rosen, B., Murphy, J., Bradley, L., Royer, R., Sun, P., & Narod, S. (2008).  Uptake of Genetic Testing in Ovarian Cancer Patients in Canada:  A Population Based Study. Gynecologic Oncology, 112(1):68-72.
  33. Metcalfe, K. (2009) Prophylactic Oophorectomy for Breast Cancer PreventionJournal of Women’s Health. 5(1):63-8. 
  34. Metcalfe, K. Poll. A., Finch, A., Horsman, D., Kim-Sing, C., Sun, P., Narod, S. (2009).  Cancer Risks in Women with a Family History of Breast and/or Ovarian Cancer who have Tested Negative for a BRCA1 or BRCA2 Mutation. British Journal of Cancer. 100(2):421-5
  35. Ertmański, S., Metcalfe, K., Trempała, J., Głowacka, M., Lubiński, J., Narod, S., & Gronwald, J. (2009).  Identification of Patients at High Risk of Psychological Distress after BRCA1 Genetic Testing, Genet Test Mol Biomarkers. 2009 Jun;13(3):325-30.
  36. Buick, C., & Metcalfe, K.  (2009)  Human Papilloma Vaccine:  An oncology nursing issue. Canadian Oncology Nursing Journal, 19(2); 60-4.  
  37. Esplen, MJ, Stuckless, N, Hunter, J, Narod, S, Liede, A, Metcalfe, K, Butler, K, Glendon, G, Irwin, E, Scott, J. (2009) The BRCA Self Concept Scale: A new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology,  
  38. Metcalfe, K., Poll, A., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P., and Narod, S. (2009).  Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women. Journal of Clinical Oncology,
  39. Metcalfe, K., Poll, A., Nanda, S., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P., and Narod, S. (2010).Satisfaction, breast cancer risk perception, and cancer-related distress in unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2Clinical Genetics.
  40. Brown, S., Osann, K., Culver, J., MacDonald, D., Sand, S., Thornton, A., Brown, D. Metcalfe, K., Burke, H., Robson, M., Grant, M., & Weitzel, J. (2010). Health literacy, numeracy, and interpretation of graphical breast cancer risk estimatesPatient Education and Counselling,
  41. Metcalfe, K., Lubinski, J., Lynch, H., Ghadirian, P., Foulkes, W., Kim-Sing, C., Neuhausen, S., Tung, N., Rosen, B., Gronwald, J., Ainsworth, P., Sweet, K., Eisen, A., Sun, P., Narod, S. (2010).  Family History of Cancer and the Risk of Cancer in Women with a BRCA1 or BRCA2 MutationJournal of the National Cancer Institute . 102(24):pp. 1874-8.
  42. Finch, AP, Metcalfe KA, Chiang JK,  Elit L,  Springate C,  Demsky R, Murphy J, Rosen B and Narod SA . (2011). The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual functioning in women who carry a BRCA mutationGynecologic Oncology 121(1):163-8
  43. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2010).  Risk of ipsilateral breast cancer  in women with a BRCA1 or BRCA2 MutationBreast Cancer Research and Treatment 127(1):287-96).
  44. Culver, J., MacDonald, J.,  Thornton, A., Sand, S., Grant, M., Bowen, D., Burke, H., Garcia, N., Metcalfe, K, & Weitzel, J. (2010).  Development and Evaluation of a Decision Aid for BRCA carriers with breast cancerJournal of Genetic Counseling 20(3):294-307.
  45. Metcalfe, K, Lynch, H, Ghadirian, P, Tung, N, Olivotto, I, Foulkes, W, Warner, E, Olopade, O, Eisen, A, Weber, B, McLennan, J, Sun, P, & Narod, S. (2011). Contralateral breast cancer risks in women with a BRCA1 or BRCA2 Mutation.  British Journal of Cancer. 104(9):1384-92
  46. Bordeleau L, Lipscombe L, Lubinski J, Ghadirian P, Foulkes WD, Neuhausen S, Ainsworth P, Pollak M, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). (2011). Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer, 117(9):1812-8.
  47. Metcalfe, K., Semple, J., Quan, ML., Vadaparampil, S., Holloway, C., Brown, M.,  Bower, B., Sun, P., & Narod, S. (2012).  Changes in Psychosocial Functioning One Year After Mastectomy Alone, Delayed Breast Reconstruction or Immediate Breast Reconstruction. Annals of Surgical Oncology. 19(1):233-41
  48. Ertmański S, Metcalfe K, Trempała J, Głowacka M, Lubiński J, Narod S, Gronwald J. (2012). Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation. Hered Cancer Clin Pract. 2012 Jan 12;10 Suppl 1:A14
  49. Lam, A., Secord, S., ButlerK, Hofer, S., Liu, E., Metcalfe K, & Zhong, T. (2012). A Breast Reconstruction Needs Assessment: How Does Self-Efficacy Affect Information Access and Preferences? Canadian Journal of Plastic Surgery, 20(1), pp. 37-42.
  50. Kotsopoulos J, Lubinski J, Salmena L, Lynch HT, Kim-Sing C, Foulkes WD, Ghadirian P, Neuhausen SL, Demsky R, Tung N, Ainsworth P, Senter L, Eisen A, Eng C, Singer C, Ginsburg O, Blum J, Huzarski T, Poll A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group (including Metcalfe, K.). (2012). Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.  Breast Cancer Research and Treatment, 14 (2).
  51. Metcalfe, K. Mian, N., Enmore, M., Poll, A., Llacuachaqui, M., Nanda, S., Sun, P., Hughes, K., &  Narod, S., (2011).  Long-Term Follow-up of Jewish Women with a BRCA1or BRCA2 Mutation who Underwent Population Genetic Screening.  Breast Cancer Research and Treatment.
  52. Wong J, D’Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H, Warner E, Franssen E, Szumacher E. (2012). Development of Patients’ Decision Aid for Older Women with Stage I Breast Cancer Considering Radiotherapy after Lumpectomy. Int J Radiat Oncol Biol Phys. 84 (1), 30-8.  
  53. Metcalfe, K., Quan, ML., Holloway, C., Eisen, A., Enmore, M., & Narod, S. (2013).  Cancer-Related Distress and Breast Cancer Risk Perception in Sisters of Newly Diagnosed Breast Cancer Patients. Cancer.
  54. Finch, A., Metcalfe, K., Chiang, J, Elit, L., McLaughlin, J., Springate, C., Esplen, MJ., Murphy, J., Rosen, B., & Narod, S. (2013).  The Impact of Prophylactic Salpingo-oophorectomy on Quality of Life and Psychological Distress in Women with a BRCA Mutation. Psycho-Oncology, 22 (1), 212-19
  55. Narod, S. Metcalfe, K., Lynch, H.T., Ghadirian, P., Robidoux, A., Tung, N., Gaughan,E., Kim-Sing, C., Olopade, O.I., Foulkes, W.D., Robson,  M., Offit, K., Jakubowska, A., Byrski, T., Huzarski, T., Sun, P., & Lubinski, J. (2013).  Should all BRCA1 Mutation Carriers with Breast Cancer Receive Chemotherapy?  Breast Cancer Research and Treatment, 138(1), 273-9. 
  56. Pal, T., Doty, A., Thompson, Z., Lee, J., Monteiro, A., Phelan, C., Lancaster, J., Metcalfe, K., Sellers, T., Vadaparampil, S., & Narod, S. (2013) Modes of Delivery of Genetic Testing Services and the Uptake of Risk Management Options in BRCA1 and BRCA2 Carriers, Clinical Genetics.
  57. Pal T, Vadaparampil S, Kim J, Xu Y, Friedman S, Narod SA, Metcalfe K. Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers. Familial Cancer. 2013 Mar 16. [Epub ahead of print]
  58. Fan, L., Sidani, S., Cooper-Brathwaite, A., & Metcalfe, K. (2013). Feasibility, Acceptability and Effects of a Foot Self-Care Educational Intervention on Minor Foot Problems in Adult Patients with Diabetes at Low Risk for Foot Ulceration: A Pilot Study. Can J Diabetes 37
  59. Semple, J., Metcalfe, K., Lynch, H., Kim-Sing, C., Senter, L., Pal, T., Ainsworth, P., Lubinski, J., Tung, N., Eng,, C., Gilchrist, D., Blum, J., Neuhausen, S., Singer, C., Sun, P., & Narod, S. (2013), International Rates of Breast Reconstruction following Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers, Annals of Surgical Oncology
  60. Metcalfe, K. Poll, A., Royer, R., Nanda, S., Llacuachaqui, M., Sun, P., & Narod, S. (2013). A Comparison of the Yield of BRCA Mutation Carriers Through the Provision of Jewish Population-Based Genetic Testing Compared to Clinical Based Genetic Testing. British Journal of Cancer
  61. Platt, J., Baxter, N., Jones, J., Metcalfe, K., Causarano, N., Hofer, S., O’Neill, A., Cheng, T., Starenkyj, E., & Zhong, T. (2013). Pre-Consultation Educational Group Intervention to Improve Shared Decision-Making in Postmastectomy Breast Reconstruction: A Mixed-Methods Pilot RCT. Trials.
  62. Fan L, Sidani S, Cooper-Brathwaite A, Metcalfe K. (2013). Improving Foot Self-Care Knowledge, Self-Efficacy, and Behaviors in Patients With type 2 Diabetes at Low Risk for Foot Ulceration: A Pilot Study. Clin Nurs Res. 2013 Jul 3
  63. Metcalfe, K., Kim-Sing, C., Ghadirian, P., Sun, P., & Narod, S. (2013). Healthcare Providers’ Recommendations for Cancer Prevention in BRCA1 and BRCA2 Mutation Carriers, Clinical Genetics